Black Rock Inc. Rapt Therapeutics, Inc. Transaction History
Black Rock Inc.
- $4.35 Trillion
- Q2 2024
A detailed history of Black Rock Inc. transactions in Rapt Therapeutics, Inc. stock. As of the latest transaction made, Black Rock Inc. holds 2,439,830 shares of RAPT stock, worth $4.22 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
2,439,830
Previous 2,472,153
1.31%
Holding current value
$4.22 Million
Previous $22.2 Million
66.48%
% of portfolio
0.0%
Previous 0.0%
Shares
13 transactions
Others Institutions Holding RAPT
# of Institutions
104Shares Held
27.1MCall Options Held
26.7KPut Options Held
2.4K-
Vanguard Group Inc Valley Forge, PA3.16MShares$5.46 Million0.0% of portfolio
-
Column Group LLC San Francisco, CA2.68MShares$4.64 Million7.75% of portfolio
-
Kingdon Capital Management, L.L.C. New York, NY1.73MShares$2.98 Million0.42% of portfolio
-
Ponoi Management, LLC San Francisco, CA1.6MShares$2.77 Million52.54% of portfolio
-
D. E. Shaw & Co., Inc. New York, NY1.05MShares$1.81 Million0.0% of portfolio
About RAPT Therapeutics, Inc.
- Ticker RAPT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 29,656,600
- Market Cap $51.3M
- Description
- RAPT Therapeutics, Inc., a clinical-stage immunology-based biopharmaceutical company, focuses on discovering, developing, and commercializing oral small molecule therapies for patients with unmet needs in oncology and inflammatory diseases. Its lead inflammation drug candidate is RPT193, a C-C motif chemokine receptor 4 (CCR4) antagonist that se...